Imaging localised dynamic changes in the nucleus accumbens following nicotine withdrawal in rats

This study utilises pharmacological functional magnetic resonance imaging (fMRI) to examine the neurobiological mechanisms through which nicotine produces dependence. Using an established regime to induce physical dependence to nicotine in rats (osmotic minipumps delivering 3.16 mg/kg/day nicotine for 7 days SC), animals were subsequently anaesthetised under urethane and positioned in a stereotaxic frame to allow collection of gradient echo whole brain images with a 4.7-T MRI spectrometer. Rats were initially scanned for 34 min (40 baseline image volumes, 1 volume per 51 s) then challenged with mecamylamine (1.0 mg/kg SC) or saline (1 ml/kg) and scanned for a further 68 min (80 image volumes). Mecamylamine precipitated highly significant positive changes in fMRI blood oxygen level dependent (BOLD) contrast that were predominantly localised to the NAc of nicotine-dependent rats. Saline-treated rats challenged with the same dose of mecamylamine exhibited similar but smaller increases in BOLD contrast although such changes were less defined around the NAc. Precipitated withdrawal also elicited statistically significant negative BOLD contrast changes in widespread cortical regions. These findings are consistent with previous neurochemical reports on decreases in dopamine in the NAc during nicotine withdrawal. This fMRI study further highlights the potential and power to image the neurobiological events during nicotine dependence.

[1]  H. Lal,et al.  A comparison of narcotic analgesics with neuroleptics on behavioral measures of dopaminergic activity. , 1975, Life sciences.

[2]  Mark R. Symms,et al.  Functional Magnetic Resonance Neuroimaging of Drug Dependence: Naloxone-Precipitated Morphine Withdrawal , 2002, NeuroImage.

[3]  N. Volkow,et al.  Inhibition of monoamine oxidase B in the brains of smokers , 1996, Nature.

[4]  H. Fibiger,et al.  Lack of tolerance to nicotine-induced dopamine release in the nucleus accumbens. , 1989, European journal of pharmacology.

[5]  J. Lake,et al.  Rodent model of nicotine abstinence syndrome , 1992, Pharmacology Biochemistry and Behavior.

[6]  J. Lake,et al.  Naloxone precipitates nicotine abstinence syndrome in the rat , 1993, Psychopharmacology.

[7]  G. Crelier,et al.  Investigation of BOLD signal dependence on cerebral blood flow and oxygen consumption: The deoxyhemoglobin dilution model , 1999, Magnetic resonance in medicine.

[8]  C. -. Lu,et al.  Levels of immunoreactive dynorphin A1-13 during development of morphine dependence in rats. , 1998, Zhongguo yao li xue bao = Acta pharmacologica Sinica.

[9]  P. Carlier,et al.  Simultaneous measurement of perfusion and oxygenation changes using a multiple gradient-echo sequence: application to human muscle study. , 1998, Magnetic resonance imaging.

[10]  T. Svensson,et al.  Behavioral manifestations of the nicotine abstinence syndrome in the rat: peripheral versus central mechanisms , 1997, Psychopharmacology.

[11]  G. Bock,et al.  Ciba Foundation Symposium 152 - The Biology of Nicotine Dependence , 1990 .

[12]  A. Simmons,et al.  Functional magnetic resonance imaging of the acute effect of intravenous heroin administration on visual activation in long-term heroin addicts: results from a feasibility study. , 1997, Drug and alcohol dependence.

[13]  P. Clarke,et al.  Mesolimbic dopamine activation--the key to nicotine reinforcement? , 2007, Ciba Foundation symposium.

[14]  G. Di Chiara,et al.  Dissociation of physical abstinence signs from changes in extracellular dopamine in the nucleus accumbens and in the prefrontal cortex of nicotine dependent rats. , 2000, Drug and alcohol dependence.

[15]  S. Matta,et al.  Nicotine stimulates the expression of cFos protein in the parvocellular paraventricular nucleus and brainstem catecholaminergic regions. , 1993, Endocrinology.

[16]  M. Benwell,et al.  Evidence that Tobacco Smoking Increases the Density of (−)‐[3H]Nicotine Binding Sites in Human Brain , 1988, Journal of neurochemistry.

[17]  Karl J. Friston,et al.  Statistical parametric maps in functional imaging: A general linear approach , 1994 .

[18]  O. Salminen,et al.  Effect of Acute Nicotine on Fos Protein Expression in Rat Brain During Chronic Nicotine and Its Withdrawal , 2000, Pharmacology Biochemistry and Behavior.

[19]  Stephen M Smith,et al.  Fast robust automated brain extraction , 2002, Human brain mapping.

[20]  N. Bruggen,et al.  Biomedical Imaging in Experimental Neuroscience , 2002 .

[21]  M. Schmid,et al.  Effects of nicotine withdrawal on central dopaminergic systems , 1996, Pharmacology Biochemistry and Behavior.

[22]  S. Hyman,et al.  Acute Effects of Cocaine on Human Brain Activity and Emotion , 1997, Neuron.

[23]  T. Svensson,et al.  Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome , 1998, Brain Research.

[24]  E. London,et al.  Effects of nicotine on local cerebral glucose utilization in the rat , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[25]  P. Flecknell,et al.  Laboratory animal anaesthesia , 1996 .

[26]  Joseph B. Mandeville,et al.  Pharmacologic Magnetic Resonance Imaging (phMRI) , 2002 .

[27]  S. Ogawa,et al.  Oxygenation‐sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields , 1990, Magnetic resonance in medicine.

[28]  K. Chergui,et al.  Nicotine injections into the ventral tegmental area increase locomotion and Fos-like immunoreactivity in the nucleus accumbens of the rat , 1996, Brain Research.

[29]  K. Perkins,et al.  Acute tolerence to nicotine in smokers: lack of dissipation within 2 hours , 1995, Psychopharmacology.

[30]  P. Clarke,et al.  Blockade of nicotinic receptor‐mediated release of dopamine from striatal synaptosomes by chlorisondamine and other nicotinic antagonists administered in vitro , 1994, British journal of pharmacology.

[31]  G. Di Chiara,et al.  Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. , 1986, European journal of pharmacology.

[32]  I. Stolerman,et al.  The neurobiology of tobacco addiction. , 1991, Trends in pharmacological sciences.

[33]  C. Chiamulera,et al.  The Reinforcing Properties of Nicotine are Associated with a Specific Patterning of c‐fos Expression in the Rat Brain , 1996, The European journal of neuroscience.

[34]  B R Rosen,et al.  Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: Correlation with PET, microdialysis, and behavioral data , 1997, Magnetic resonance in medicine.

[35]  L. Pellegrino,et al.  stereotaxic atlas of the rat brain , 1967 .

[36]  W. Kuschinsky,et al.  Effects of nicotine withdrawal on the local cerebral glucose utilization in conscious rats , 1991, Brain Research.

[37]  G. Koob,et al.  Dramatic decreases in brain reward function during nicotine withdrawal , 1998, Nature.

[38]  C. Chiamulera,et al.  Common Neural Substrates for the Addictive Properties of Nicotine and Cocaine , 1997, Science.

[39]  T. Svensson,et al.  Behavioral and Biochemical Manifestations of Mecamylamine-Precipitated Nicotine Withdrawal in the Rat: Role of Nicotinic Receptors in the Ventral Tegmental Area , 1999, Neuropsychopharmacology.

[40]  Betty Jo Salmeron,et al.  Pharmacological applications of magnetic resonance imaging. , 2002, Psychopharmacology bulletin.

[41]  Rainer Spanagel,et al.  Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway , 1992 .

[42]  Douglas C. Noll,et al.  Suppression of Vascular Artifacts in Functional Magnetic Resonance Images Using MR Angiograms , 1998, NeuroImage.

[43]  P. Clarke,et al.  Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [125I]-alpha-bungarotoxin , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[44]  Karl J. Friston,et al.  Analysis of fMRI Time-Series Revisited—Again , 1995, NeuroImage.

[45]  R. Spanagel Modulation of drug-induced sensitization processes by endogenous opioid systems , 1995, Behavioural Brain Research.

[46]  O. Salminen,et al.  Expression of fos protein in various rat brain areas following acute nicotine and diazepam , 1996, Pharmacology Biochemistry and Behavior.

[47]  G. Koob,et al.  Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects. , 2000, The Journal of pharmacology and experimental therapeutics.

[48]  M. Jarvis,et al.  The scientific case that nicotine is addictive , 2005, Psychopharmacology.

[49]  T. Svensson,et al.  Selective c‐fos induction and decreased dopamine release in the central nucleus of amygdala in rats displaying a mecamylamine‐precipitated nicotine withdrawal syndrome , 2000, Synapse.

[50]  M. Bock,et al.  The relationship between the BOLD‐induced T2 and T  2* : A theoretical approach for the vasculature of myocardium , 1999, Magnetic resonance in medicine.

[51]  R S Balaban,et al.  Challenges in small animal noninvasive imaging. , 2001, ILAR journal.

[52]  M. Reivich,et al.  THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT 1 , 1977, Journal of neurochemistry.

[53]  E. London,et al.  Effects of chronic nicotine on cerebral glucose utilization in the rat , 1990, Brain Research.

[54]  A. Markou,et al.  Increased GABA neurotransmission via administration of gamma‐vinyl GABA decreased nicotine self‐administration in the rat , 2002, Synapse.

[55]  T. George,et al.  Mecamylamine: new therapeutic uses and toxicity/risk profile. , 2001, Clinical therapeutics.

[56]  M. James,et al.  Pharmacological magnetic resonance imaging: a new application for functional MRI. , 2000, Trends in pharmacological sciences.

[57]  R G Hoffmann,et al.  Nicotine-induced limbic cortical activation in the human brain: a functional MRI study. , 1998, The American journal of psychiatry.

[58]  W. Corrigall,et al.  GABA mechanisms in the pedunculopontine tegmental nucleus influence particular aspects of nicotine self-administration selectively in the rat , 2001, Psychopharmacology.